| Name | Title | Contact Details |
|---|
Beverly Oncology & Imaging Centers, Medical Group is a Montebello, CA-based company in the Business Services sector.
TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes. TIXiMED is the exclusive license holder for the patent (composition of matter and method of use) surrounding TIX100, a novel small molecule that normalizes pancreatic beta cell TXNIP, a detrimental protein elevated in Type 1 and Type 2 diabetes. Increased TXNIP causes pancreatic islet dysfunction and death of insulin-producing beta cells and thereby contributes to the development and progression of diabetes. Diabetes affects more than half a billion people worldwide. Those affected by Type 1 diabetes are dependent on multiple daily insulin injections or continuous insulin infusions to stay alive and manage their blood sugar. Oral anti-diabetic drugs are only approved for Type 2 diabetes, but can be associated with multiple side effects, underlining the need for novel and better oral diabetes medications for Type 1 and Type 2 diabetes. TXNIP inhibition has recently been demonstrated to be an effective and safe therapeutic approach in adults and children with recent onset Type 1 diabetes and TIX100 shows beneficial, anti-diabetic effects in 4 different mouse models. Advantages of TIX100 include oral availability, no associated hypoglycemia or weight gain, potent inhibition of detrimental TXNIP in human islets, and a favorable pharmacokinetic and safety profile. In addition, TIX100 inhibits excessive glucagon secretion and hepatic glucose production and protects against fatty liver. Thus, TIX100 holds promise for durable, weight-neutral improvement in glycemic control in Type 1 and Type 2 diabetes by targeting common underlying pathology and promoting patients own islet cell health.
Financial Consultants is a Gibbsboro, NJ-based company in the Business Services sector.
Ayars & Ayars is one of the leading providers in Business Services. It is based in Omaha, NE. To find more information about Ayars & Ayars, please visit www.ayarsayars.com.
Element Three is a full-service marketing agency based in Indianapolis, Indiana. We take an accountable approach to marketing, ensuring every strategy developed and tactic applied is aimed at making a positive impact on your business and brand. From complete rebrands and seamless online experiences to digital advertising and beyond, we help clients in the outdoor, technology, and specialty healthcare industries reach their full potential.